<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><span >This is a condition in which the heart is unable to produce adequate cardiac output, and in so doing, is unable to meet the body's metabolic requirements. The cardiac dysfunction may predominantly involve the left or the right ventricle individually or both ventricles simultaneously. This later case is termed Biventricular Failure(BVF) or Congestive Cardiac Failure (CCF).</span></p><p style="text-align:justify;"><span >The functional classification of heart failure using the New York Heart Association (NYHA) Classification is described in the table below.</span>

    <div style="width: 95vw;">
        <img src="https://osamfrimpong.github.io/stg_app_web/images/heart_failure_classification.png" alt="Heart Failure Classification" style="max-width: 100%;height: auto;margin: auto;">
    </div>

</p><h3>CAUSES</h3><p> • Systemic arterial hypertension</p><p> • Rheumatic heart disease</p><p> • Cardiomyopathies</p><p> • Severe anaemia</p><p> • Ischaemic heart disease</p><p> • Thyrotoxicosis</p><p> • Congenital heart disease</p><p> • Pulmonary arterial hypertension</p><p> • Cardiac arrhythmia</p><h3>SYMPTOMS</h3><p><strong>Left Heart Failure</strong></p><p> • Breathlessness</p><ul><li>On exertion</li><li>On lying flat (orthopnoea)</li><li>At night (paroxysmal nocturnal dyspnoea)</li></ul><p> • Easy fatiguability</p><p> • Cough with frothy blood-stained sputum</p><p> • Wheezing</p><h3>Right Heart Failure</h3><p> • Swelling of the feet and lower extremities (may be absent in children below 6 months)</p><p> • Abdominal swelling</p><p> • Right hypochondrial pain from an enlarging liver</p><h3>SIGNS</h3><p><strong>Left Heart Failure</strong></p><p> • Tachypnoea</p><p> • Tachycardia</p><p> • Basal crepitations</p><p> • Gallop rhythm</p><p> • Displaced apex beat</p><p> • Cardiac murmur</p><p> • Rhonchi</p><h3>Right Heart Failure</h3><p> • Tachycardia</p><p> • Pitting pedal oedema (may be absent in children below 6 months)</p><p> • Ascites</p><p> • Tender, smooth, soft hepatomegaly</p><p> • Raised jugular venous pressure</p><p> • Gallop rhythm</p><p> • Cardiac murmur</p><h3>In children</h3><p> • Failure to thrive</p><p> • Difficulty in feeding</p><h3>INVESTIGATIONS</h3><p> • FBC</p><p> • ECG</p><p> • Chest X-ray</p><p> • Blood urea, electrolytes and creatinine and eGFR (estimated glomerular filtration rate)</p><p> • Liver function test</p><p> • Fasting blood sugar</p><p> • Fasting lipids</p><p> • Echocardiography</p><p> • Thyroid function tests</p><p> • Cardiac enzymes, if myocardial infarction is suspected</p><p> • Coronary angiography</p><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><p> • To relieve symptoms and improve quality of life</p><p> • To treat the precipitating cause</p><p> • To treat complications</p><p> • To prevent recurrence of symptoms</p><p> • To reduce need for hospital re-admissions</p><p> • To reduce mortality</p><h3>Non-pharmacological treatment</h3><ul><li>Reduce salt intake</li><li>Reduce weight in overweight and obese individuals</li><li>Avoid alcohol</li><li>Avoid or quit smoking</li><li>Encourage moderate exercise</li><li>Bed rest (only in acute heart failure or exacerbations of chronic heart failure)</li><li>Prop up in bed</li></ul><h3>Pharmacological treatment</h3><p><span ><strong>A.  Acute heart failure - initial treatment</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Oxygen, by nasal cannula or face mask if there is hypoxaemia (SpO2 &lt; 90%)</li></ul><p><span >And</span></p><ul><li>Furosemide, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>40-80 mg, repeat after 30 minutes if necessary</p><p><strong><u>Children</u></strong></p><p>12-18 years;  20-40 mg repeated 8 hourly as necessary</p><p>1 month-12 years; 0.5-1 mg/kg repeated 8 hourly (max 4 mg/ kg/dose)</p><p><span ><strong>B. Acute heart failure - maintenance treatment after stabilisation</strong></span></p><ul><li>Furosemide, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>40-80 mg 12 hourly</p><p><strong><u>Children</u></strong></p><p>12-18 years; 20-40 mg repeated 8 hourly as necessary</p><p>1 month-12years; 0.5-1 mg/kg repeated 8 hourly (max 4 mg/ kg/dose)</p><p><span ><strong>C. Acute heart failure - patient not improving after initial treatment</strong></span></p><ul><li>Furosemide (Frusemide), IV,</li></ul><p><strong><u>Adults</u></strong></p><p>40-80 mg 12 hourly</p><p><strong><u>Children</u></strong></p><p>12-18 years; 20-40 mg repeated 8 hourly as necessary</p><p>1 month-12years;  0.5-1 mg/kg repeated 8 hourly (max 4 mg/ kg/dose)</p><h3>And</h3><p> • Morphine, IV,</p><p><strong><u>Adults</u></strong></p><p>5-10 mg slowly</p><p><strong><u>Children</u></strong></p><p>Not recommended for this condition as safety is not well established</p><h3>And</h3><ul><li>Metoclopramide, IV,</li></ul><p><strong><u>Adults</u></strong></p><p>10 mg to prevent vomiting</p><p><strong><u>Children</u></strong></p><p>Not required</p><p><span ><strong>D. Acute heart failure - patient improving after initial treatment</strong></span></p><ul><li>Furosemide, oral,</li></ul><p><strong><u>Adults</u></strong></p><p>40-80 mg 12 hourly</p><p><strong><u>Children</u></strong></p><p>0.5-2 mg/kg 8-12 hourly</p><p><span ><strong>E. Acute heart failure - patient with fast atrial fibrillation or in sinus rhythm with systolic dysfunction</strong></span></p><p><span ><strong>Evidence Rating: [C]</strong></span></p><ul><li>Digoxin, oral,</li></ul><p><strong>Elderly</strong></p><p>125 micrograms 12 hourly for 24-48 hours</p><p><strong><u>Adults</u></strong></p><p>250 micrograms 12 hourly for 24-48 hours</p><h3>Then</h3><p>250 micrograms daily</p><h3>Then</h3><p>125 micrograms daily</p><p><strong><u>Children</u> &gt; 10 years</strong></p><p>0.5-1 mg in 3 divided doses over 24 hours</p><h3>Then</h3><p>62.5-250 microgram daily</p><p><strong><u>Children</u> 2-10 years</strong></p><p>20-30 microgram/kg in 3 divided doses over 24 hours</p><h3>Then</h3><p>8-10 microgram/kg daily</p><p><strong><u>Children</u> &lt; 2 years</strong></p><p>30-40 microgram/kg in 3 divided doses over 24 hours</p><h3>Then</h3><p>10-12 microgram /kg daily</p><p><strong><u>Neonates</u> (full term)</strong></p><p>20 microgram/kg in 3 divided doses in 24 hours</p><h3>Then</h3><p>8-10 microgram/kg daily</p><p><strong><u>Neonates</u> ( &lt; 1.5 kg)</strong></p><p>25 microgram/kg in 3 divided doses in 24 hours </p><p>Premature</p><p>15 microgram/kg daily</p><h3>Then</h3><p>5 microgram/kg daily</p><p><span ><strong>F. Acute heart failure - patients in cardiogenic shock (adult systolic blood pressure &lt;85mmHg) with hypotension and or hypoperfusion</strong></span></p><ul><li>Dobutamine, IV infusion,</li></ul><p><strong><u>Adults</u></strong><br>2.5-10 micrograms/kg per minute</p><p><span ><strong>G. Prophylactic anticoagulation against venous thrombosis</strong></span></p><ul><li>Enoxaparin, SC,</li></ul><p><strong><u>Adults</u></strong></p><p>1.5 mg/kg (150 units/kg) daily</p><p><strong><u>Children</u></strong></p><p>2 months-18 years;   1 mg/kg 12 hourly</p><p>1-2 months;   1.5 mg/kg 12 hourly</p><p><u>Neonates</u>;  1.5-2 mg/kg 12 hourly</p><p> • Identify and treat (if possible) precipitating causes such as hypertension, myocardial infarction, anaemia or thyrotoxicosis</p><p><span ><strong>H. Symptomatic Heart Failure</strong></span></p><p><span ><strong>1<sup>st</sup> Line Treatment</strong></span></p><p> • Furosemide, oral,<span > </span></p><p><span ><strong>Evidence Rating: [C]</strong></span><strong><u> </u></strong></p><p><strong><u>Adults</u></strong></p><p>40-80 mg daily</p><p><strong><u>Children</u></strong></p><p>1-2 mg/kg daily</p><h3>And</h3><p> • Lisinopril, oral,</p><p><span >(only when systolic blood pressure &gt; 100 mmHg)</span></p><p><span ><strong> Evidence Rating: [A]</strong></span></p><p><u>Adults</u></p><p>2.5-20 mg daily</p><h3>Or</h3><p> • Ramipril, oral,</p><p><span >(only when systolic blood pressure &gt; 100 mmHg )</span></p><p><span ><strong> Evidence Rating: [A]</strong></span></p><p><strong><u>Adults</u></strong></p><p>2.5-10 mg daily</p><h3>And</h3><p> • Carvedilol, oral,<span > Evidence Rating: [A]</span></p><p><strong><u>Adults</u></strong></p><p>3.125-12.5 mg 12 hourly (maximum 25mg 12 hourly)</p><h3>Or</h3><ul><li>Bisoprolol, oral,<span > </span></li></ul><p><span ><strong>Evidence Rating: [A]</strong></span></p><p><strong><u> Adults</u></strong></p><p>1.25-10 mg daily</p><h3>Or</h3><ul><li>Metoprolol, oral,</li></ul><p><span > Evidence Rating: [A]</span></p><p><strong><u>Adults</u></strong></p><p><strong>25-100 mg daily</strong></p><p><span ><strong>I. Patients not tolerating ACE inhibitors (replace Lisinopril or Ramipril with the following in the 1st line treatment above)</strong></span></p><ul><li>Losartan, oral,<span > </span></li></ul><p><span ><strong>Evidence Rating: [A]</strong></span></p><p><strong><u> Adults</u></strong></p><p>25-50 mg daily</p><h3>Or</h3><ul><li>Candesartan, oral,<span > </span></li></ul><p><span ><strong>Evidence Rating: [A]</strong></span><strong><u> </u></strong></p><p><strong><u>Adults</u></strong></p><p>4-16 mg daily</p><p><span ><strong>J.  Patients with fast atrial fibrillation or in sinus rhythm with systolic dysfunction;</strong></span></p><h3>Add</h3><ul><li>Digoxin, oral,<span > </span></li></ul><p><span ><strong>Evidence Rating: [B]</strong></span><strong> </strong></p><p><strong>Elderly</strong></p><p>125 micrograms 12 hourly for 24-48 hours,</p><p><strong>Then</strong></p><p>125 micrograms 24 hourly</p><p><strong><u>Adults</u></strong></p><p>250 micrograms 12 hourly for 24-48 hours,</p><h3>Then</h3><p>250 micrograms once daily</p><p><strong><u>Children</u></strong></p><p>5 micrograms/kg 12 hourly</p><p><span ><strong>K. Symptomatic patients, inspite of the above medications</strong></span><strong> </strong></p><p><strong>And</strong></p><p style="text-align:justify;"> •Spironolactone, oral,<span > </span></p><p style="text-align:justify;"><span ><strong>Evidence Rating: [A]</strong></span><strong><u> </u></strong></p><p style="text-align:justify;"><strong><u>Adults</u></strong></p><p style="text-align:justify;">25-50 mg daily</p><h3>REFERRAL</h3><p style="text-align:justify;"><span >All patients must be referred to a specialist when clinically stable for the identification and treatment of the underlying cause of the heart failure and for long-term maintenance therapy.</span></p>

    <p><strong> FLOWCHART</strong></p>
<div style="width: 95vw;">
<img src="https://osamfrimpong.github.io/stg_app_web/images/heart_failure.png" alt="Flowchart: Heart Failure" style="max-width: 100%;height: auto;margin: auto;">
</div>
<p><br /><strong>Fig 7-5: Flowchart: Heart Failure</strong></p>

</body>
</html>
